To enhance the program’s academic presence, we a
Post# of 151586
(Total Views: 667)
Posted On: 11/18/2024 8:11:24 PM
Quote:
To enhance the program’s academic presence, we actively participate in cutting-edge bench-to-bedside clinical research such as the treatment of lung failure associated with COVID by utilizing stem cells and smart molecules (e.g. leronlimab and axatilimab).
However, this article doesn't indicate a trial is underway with LL.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼